AstraZeneca Pharma share price rises 3% on CDSCO nod for Eculizumab
AstraZeneca share rose after it that the company has secured permission to import pharmaceutical formulations of new drug for ...
Zacks.com on MSN12d
AstraZeneca Stock Down Almost 14% in 3 Months: Time to Sell?
AstraZeneca AZN stock has declined 14% in the past three months. A lot of this price decline is due to ongoing investigations at its China subsidiary. However, the overall drug and biotech sector has ...
Hosted on MSN10d
Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest trading session, Astrazeneca (AZN) closed at $66.58, marking a -0.09% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.16%. Elsewhere, the Dow ...
Medindia26d
Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia
Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced the company has partnered ...